neurocare group AG obtains patent grant on treatment method for neuromodulation in Japan
June 23, 2022 11:00 ET
|
neurocare group AG
MUNICH, June 23, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
Global Neuromodulation Market (2022 to 2028) - Size, Share & Industry Trends Analysis Report
June 17, 2022 05:53 ET
|
Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "Global Neuromodulation Market By Technology (Internal and External), By Biomaterial, By Application, By Regional Outlook and Forecast, 2022 - 2028"...
Neurotech Devices Market worth USD 35.5 billion by 2030, Says Global Market Insights Inc.
May 25, 2022 07:15 ET
|
Global Market Insights Inc.
Selbyville, Delaware, May 25, 2022 (GLOBE NEWSWIRE) -- The neurotech devices market value is expected to reach USD 35.5 billion by 2030, according to a new research report by Global Market...
Micro-Leads Receives FDA IDE Approval for 60-Electrode Spinal Cord Stimulator System
May 21, 2022 15:46 ET
|
Micro-Leads Inc.
SOMERVILLE, Mass., May 21, 2022 (GLOBE NEWSWIRE) -- Micro-Leads Inc, a medical device technology company today announced FDA Investigational Device Exemption (IDE) approval for its high-definition...
Olympic Ophthalmics Announces FDA Clearance and Availability of Its Next-Generation iTEAR100 Neurostimulation Device, Expanded Patent Portfolio, and Further Clinical Studies
March 30, 2022 09:00 ET
|
Olympic Ophthalmics
ISSAQUAH, Wash., March 30, 2022 (GLOBE NEWSWIRE) -- Olympic Ophthalmics announced today that the U.S. Food and Drug Administration (FDA) has granted its 510(K) request for its second-generation...
Prolonged Temporary Neurostimulation Treatment Period Offered by the SPRINT® PNS System May Optimize Pain Management Care Pathway While Reducing Healthcare Costs
March 15, 2022 10:31 ET
|
SPR Therapeutics, Inc.
CLEVELAND, March 15, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced publication of a study in the Journal of Pain Research demonstrating how a longer initial treatment period may better...
PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
March 07, 2022 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, March 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
PathMaker Neurosystems Awarded CERF Medical Electronics Prize for Amyotrophic Lateral Sclerosis
February 07, 2022 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
Integer Holdings Corporation Completes Acquisition of Oscor, Inc.
December 02, 2021 08:30 ET
|
Integer Holdings Corporation
PLANO, Texas, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer today announced the close of its acquisition of...
Global Neuroprotection Markets to 2030: Major World Markets, Promising Areas of Research, Biological Therapies, Unmet Needs
November 23, 2021 06:18 ET
|
Research and Markets
Dublin, Nov. 23, 2021 (GLOBE NEWSWIRE) -- The "Neuroprotection - Methods, Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...